31
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      eEduHeart I: A Multicenter, Randomized, Controlled Trial Investigating the Effectiveness of a Cardiac Web-Based eLearning Platform - Rationale and Study Design

      research-article

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objectives: Cardiac telerehabilitation includes, in its most comprehensive format, telemonitoring, telecoaching, social interaction, and eLearning. The specific role of eLearning, however, was seldom assessed. The aim of eEduHeart I is to investigate the medium-term effectiveness of the addition of a cardiac web-based eLearing platform to conventional cardiac care. Methods: In this prospective, multicenter randomized, controlled trial, 1,000 patients with coronary artery disease will be randomized 1:1 to an intervention group (receiving 1-month unrestricted access to the cardiac eLearning platform in addition to conventional cardiac care) or to conventional cardiac care alone. The primary endpoint is health-related quality of life, assessed by the HeartQoL questionnaire at the 1- and 3-month follow-ups. Secondary endpoints include pathology-specific knowledge and self-reported eLearning platform user experience. Data on the eLearning platform usage will be gathered through web logging during the study period. Results: eEduHeart I will be one of the first studies to report on the added value of eLearning. Conclusions: If the intervention is proven effective, current cardiac telerehabilitation programs can be augmented by including eLearning, too. The platform can then be used as a model for other chronic diseases in which patient education plays a key role.

          Related collections

          Author and article information

          Journal
          CRD
          Cardiology
          10.1159/issn.0008-6312
          Cardiology
          S. Karger AG
          0008-6312
          1421-9751
          2017
          February 2017
          23 September 2016
          : 136
          : 3
          : 157-163
          Affiliations
          aDepartment of Cardiology, Jessa Hospital, Hasselt, bFaculty of Medicine and Life Sciences, Hasselt University, Diepenbeek, cFaculty of Medicine and Health Sciences, Antwerp University, Antwerpen, and dDepartment of Cardiology, Hospital East-Limburg, Genk, Belgium
          Author notes
          *Ines Frederix, Beatrijslaan 105, BE-3110 Rotselaar (Belgium), E-Mail ines.frederix@gmail.com
          Author information
          https://orcid.org/0000-0001-8636-5972
          Article
          448393 Cardiology 2017;136:157-163
          10.1159/000448393
          27657799
          87fa6802-6cd1-44f1-9e26-dcb84b3a30f4
          © 2016 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          History
          : 28 April 2016
          : 13 July 2016
          Page count
          Figures: 1, Tables: 1, References: 18, Pages: 7
          Categories
          Original Research - Clinical Trial Design

          General medicine,Neurology,Cardiovascular Medicine,Internal medicine,Nephrology
          Intervention trial,eLearning,Cardiovascular disease,Cardiac telerehabilitation

          Comments

          Comment on this article